-
1
-
-
0020685572
-
The C5a receptor of neutrophils and macrophages
-
Chenoweth DE, Goodman MG. The C5a receptor of neutrophils and macrophages. Agents Actions Suppl. 1983;12:252-273.
-
(1983)
Agents Actions Suppl
, vol.12
, pp. 252-273
-
-
Chenoweth, D.E.1
Goodman, M.G.2
-
2
-
-
0031036877
-
C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in urticaria pigmentosa by immunohistochemistry
-
DOI 10.1007/s004030050159
-
Werfel T, Oppermann M, Begemann G, et al. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry. Arch Dermatol Res. 1997;289:83-86. (Pubitemid 27075572)
-
(1997)
Archives of Dermatological Research
, vol.289
, Issue.2
, pp. 83-86
-
-
Werfel, T.1
Oppermann, M.2
Begemann, G.3
Gotze, O.4
Zwirner, J.5
-
3
-
-
0029814326
-
Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells
-
Morelli A, Larregina A, Chuluyan I, et al. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology. 1996;89:126-134.
-
(1996)
Immunology
, vol.89
, pp. 126-134
-
-
Morelli, A.1
Larregina, A.2
Chuluyan, I.3
-
4
-
-
0028930272
-
Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells
-
Wetsel RA. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Immunol Lett. 1995;44:183-187.
-
(1995)
Immunol Lett.
, vol.44
, pp. 183-187
-
-
Wetsel, R.A.1
-
5
-
-
33644643770
-
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma
-
DOI 10.1172/JCI26582
-
Kohl J, Baelder R, Lewkowich IP, et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest. 2006;116:783-796. (Pubitemid 43326888)
-
(2006)
Journal of Clinical Investigation
, vol.116
, Issue.3
, pp. 783-796
-
-
Kohl, J.1
Baelder, R.2
Lewkowich, I.P.3
Pandey, M.K.4
Hawlisch, H.5
Wang, L.6
Best, J.7
Herman, N.S.8
Sproles, A.A.9
Zwirner, J.10
Whitsett, J.A.11
Gerard, C.12
Sfyroera, G.13
Lambris, J.D.14
Wills-Karp, M.15
-
6
-
-
33645918313
-
1pr mice
-
DOI 10.1681/ASN.2005040373
-
Wenderfer SE, Ke B, Hollmann TJ, et al. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J Am Soc Nephrol. 2005;16:3572-3582. (Pubitemid 46211278)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.12
, pp. 3572-3582
-
-
Wenderfer, S.E.1
Ke, B.2
Hollmann, T.J.3
Wetsel, R.A.4
Lan, H.Y.5
Braun, M.C.6
-
7
-
-
0035865055
-
A novel role of complement: Mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration
-
Mastellos D, Papadimitriou JC, Franchini S, et al. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol. 2001;166:2479-2486.
-
(2001)
J Immunol
, vol.166
, pp. 2479-2486
-
-
Mastellos, D.1
Papadimitriou, J.C.2
Franchini, S.3
-
8
-
-
0141449968
-
The proinflammatory mediators C3a and C5a are essential for liver regeneration
-
DOI 10.1084/jem.20030374
-
Strey CW, Markiewski M, Mastellos D, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med. 2003;198:913-923. (Pubitemid 37152928)
-
(2003)
Journal of Experimental Medicine
, vol.198
, Issue.6
, pp. 913-923
-
-
Strey, C.W.1
Markiewski, M.2
Mastellos, D.3
Tudoran, R.4
Spruce, L.A.5
Greenbaum, L.E.6
Lambris, J.D.7
-
9
-
-
4444334311
-
Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells
-
Ratajczak MZ, Reca R, Wysoczynski M, et al. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells. Leukemia. 2004;18:1482-1490.
-
(2004)
Leukemia
, vol.18
, pp. 1482-1490
-
-
Ratajczak, M.Z.1
Reca, R.2
Wysoczynski, M.3
-
10
-
-
0001754187
-
Anaphylatoxins and biological responses
-
Volanakis J, Frank M, eds. New York: Marcel Dekker
-
Ember JA, Jagels M, Hugli T. Anaphylatoxins and biological responses. In: Volanakis J, Frank M, eds. The human complement system in health and disease. New York: Marcel Dekker; 1998:241-284.
-
(1998)
The Human Complement System in Health and Disease
, pp. 241-284
-
-
Ember, J.A.1
Jagels, M.2
Hugli, T.3
-
12
-
-
34248582436
-
Innovative therapeutics for inflammatory bowel disease
-
Yamamoto-Furusho JK. Innovative therapeutics for inflammatory bowel disease. World J Gastroenterol. 2007;13:1893-1896. (Pubitemid 46746374)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.13
, pp. 1893-1896
-
-
Yamamoto-Furusho, J.K.1
-
13
-
-
30344448250
-
Toxicity of infliximab in the course of treatment of Crohn's disease
-
DOI 10.1517/14740338.5.1.9
-
Bratcher JM, Korelitz BI. Toxicity of infliximab in the course of treatment of Crohn's disease. Expert Opin Drug Saf. 2006;5:9-16. (Pubitemid 43056435)
-
(2006)
Expert Opinion on Drug Safety
, vol.5
, Issue.1
, pp. 9-16
-
-
Bratcher, J.M.1
Korelitz, B.I.2
-
14
-
-
9244231203
-
Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC)
-
Ueki T, Mizuno M, Uesu T, et al. Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC). Clin Exp Immunol. 1996;104:286-292. (Pubitemid 26135444)
-
(1996)
Clinical and Experimental Immunology
, vol.104
, Issue.2
, pp. 286-292
-
-
Ueki, T.1
Mizuno, M.2
Uesu, T.3
Kiso, T.4
Nasu, J.5
Inaba, T.6
Kihara, Y.7
Matsuoka, Y.8
Okada, H.9
Fujita, T.10
Tsuji, T.11
-
15
-
-
0025917506
-
Local complement activation in inflammatory bowel disease
-
Halstensen TS, Brandtzaeg P. Local complement activation in inflammatory bowel disease. Immunol Res. 1991;10:485-492.
-
(1991)
Immunol Res
, vol.10
, pp. 485-492
-
-
Halstensen, T.S.1
Brandtzaeg, P.2
-
16
-
-
0026649732
-
Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis
-
Halstensen TS, Mollnes TE, Garred P, et al. Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis. Gut. 1992;33:902-908.
-
(1992)
Gut
, vol.33
, pp. 902-908
-
-
Halstensen, T.S.1
Mollnes, T.E.2
Garred, P.3
-
17
-
-
0033428117
-
Decreased expression of protectin (CD59) in gut epithelium in ulcerative colitis and Crohn's disease
-
Scheinin T, Bohling T, Halme L, et al. Decreased expression of protectin (CD59) in gut epithelium in ulcerative colitis and Crohn's disease. Hum Pathol. 1999;30:1427-1430. (Pubitemid 30032917)
-
(1999)
Human Pathology
, vol.30
, Issue.12
, pp. 1427-1430
-
-
Scheinin, T.1
Bohling, T.2
Halme, L.3
Kontiainen, S.4
Bjorge, L.5
Meri, S.6
-
18
-
-
33644672010
-
Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5
-
Deguchi Y, Andoh A, Inatomi O, et al. Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5. Int J Mol Med. 2005;16:605-608.
-
(2005)
Int J Mol Med
, vol.16
, pp. 605-608
-
-
Deguchi, Y.1
Andoh, A.2
Inatomi, O.3
-
19
-
-
1542619243
-
Decay-Accelerating Factor Deficiency Increases Susceptibility to Dextran Sulfate Sodium-Induced Colitis: Role for Complement in Inflammatory Bowel Disease
-
Lin F, Spencer D, Hatala DA, et al. Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease. J Immunol. 2004;172:3836-3841. (Pubitemid 38337970)
-
(2004)
Journal of Immunology
, vol.172
, Issue.6
, pp. 3836-3841
-
-
Lin, F.1
Spencer, D.2
Hatala, D.A.3
Levine, A.D.4
Medof, M.E.5
-
20
-
-
0242494255
-
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease
-
Woodruff TM, Arumugam TV, Shiels IA, et al. A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J Immunol. 2003;171:5514-5520.
-
(2003)
J Immunol
, vol.171
, pp. 5514-5520
-
-
Woodruff, T.M.1
Arumugam, T.V.2
Shiels, I.A.3
-
21
-
-
22944465759
-
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease
-
DOI 10.1124/jpet.105.086835
-
Woodruff TM, Pollitt S, Proctor LM, et al. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease. J Pharmacol Exp Ther. 2005;314:811-817. (Pubitemid 41043866)
-
(2005)
Journal of Pharmacology and Experimental Therapeutics
, vol.314
, Issue.2
, pp. 811-817
-
-
Woodruff, T.M.1
Pollitt, S.2
Proctor, L.M.3
Stocks, S.Z.4
Manthey, H.D.5
Williams, H.M.6
Mahadevan, I.B.7
Shiels, I.A.8
Taylor, S.M.9
-
22
-
-
0029795542
-
The C5a chemoattractant receptor mediates mucosal defence to infection
-
DOI 10.1038/383086a0
-
Hopken UE, Lu B, Gerard NP, et al. The C5a chemoattractant receptor mediates mucosal defence to infection [see Comments]. Nature. 1996;383:86-89. (Pubitemid 26296466)
-
(1996)
Nature
, vol.383
, Issue.6595
, pp. 86-89
-
-
Hopken, U.E.1
Lu, B.2
Gerard, N.P.3
Gerard, C.4
-
23
-
-
0036145133
-
Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units
-
DOI 10.1258/0023677021911740
-
Nicklas W, Baneux P, Boot R, et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim. 2002;36:20-42. (Pubitemid 34073119)
-
(2002)
Laboratory Animals
, vol.36
, Issue.1
, pp. 20-42
-
-
Nicklas, W.1
Baneux, P.2
Boot, R.3
Decelle, T.4
Deeny, A.A.5
Fumanelli, M.6
Illgen-Wilcke, B.7
-
24
-
-
11244313308
-
Refined histopathologic scoring system improves power to detect colitis QTL in mice
-
DOI 10.1007/s00335-004-2392-2
-
Bleich A, Mahler M, Most C, et al. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome. 2004;15:865-871. (Pubitemid 40064197)
-
(2004)
Mammalian Genome
, vol.15
, Issue.11
, pp. 865-871
-
-
Bleich, A.1
Mahler, M.2
Most, C.3
Leiter, E.H.4
Liebler-Tenorio, E.5
Elson, C.O.6
Hedrich, H.J.7
Schlegelberger, B.8
Sundberg, J.P.9
-
25
-
-
24144461193
-
CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation
-
DOI 10.1053/j.gastro.2005.06.061, PII S0016508505013478
-
Obermeier F, Dunger N, Strauch UG, et al. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology. 2005;129:913-927. (Pubitemid 41242684)
-
(2005)
Gastroenterology
, vol.129
, Issue.3
, pp. 913-927
-
-
Obermeier, F.1
Dunger, N.2
Strauch, U.G.3
Hofmann, C.4
Bleich, A.5
Grunwald, N.6
Hedrich, H.J.7
Aschenbrenner, E.8
Schlegelberger, B.9
Rogler, G.10
Scholmerich, J.11
Falk, W.12
-
26
-
-
0034548808
-
Immunology of inflammatory bowel diseases
-
Lakatos L. Immunology of inflammatory bowel diseases. Acta Physiol Hung. 2000;87:355-372.
-
(2000)
Acta Physiol Hung
, vol.87
, pp. 355-372
-
-
Lakatos, L.1
-
27
-
-
0031736096
-
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
-
DOI 10.1046/j.1365-2249.1998.00728.x
-
Dieleman LA, Palmen MJ, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114:385-391. (Pubitemid 28539597)
-
(1998)
Clinical and Experimental Immunology
, vol.114
, Issue.3
, pp. 385-391
-
-
Dieleman, L.A.1
Palmen, M.J.H.J.2
Akol, H.3
Bloemena, E.4
Pena, A.S.5
Meuwissen, S.G.M.6
Van Rees, E.P.7
-
28
-
-
0031736096
-
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines
-
DOI 10.1046/j.1365-2249.1998.00728.x
-
Dieleman LA, Palmen MJ, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114:385-391. (Pubitemid 28539597)
-
(1998)
Clinical and Experimental Immunology
, vol.114
, Issue.3
, pp. 385-391
-
-
Dieleman, L.A.1
Palmen, M.J.H.J.2
Akol, H.3
Bloemena, E.4
Pena, A.S.5
Meuwissen, S.G.M.6
Van Rees, E.P.7
-
29
-
-
0030739649
-
The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes
-
DOI 10.1084/jem.186.2.199
-
Martin U, Bock D, Arseniev L, et al. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes. J Exp Med. 1997;186:199-207. (Pubitemid 27328020)
-
(1997)
Journal of Experimental Medicine
, vol.186
, Issue.2
, pp. 199-207
-
-
Martin, U.1
Bock, D.2
Arseniev, L.3
Tornetta, M.A.4
Ames, R.S.5
Bautsch, W.6
Kohl, J.7
Ganser, A.8
Klos, A.9
-
30
-
-
20444460795
-
Evidence for a functional role of the second C5a receptor C5L2
-
DOI 10.1096/fj.04-3424fje
-
Gao H, Neff TA, Guo RF, et al. Evidence for a functional role of the second C5a receptor C5L2. FASEB J. 2005;19:1003-1005. (Pubitemid 40827732)
-
(2005)
FASEB Journal
, vol.19
, Issue.8
, pp. 1003-1005
-
-
Gao, H.1
Neff, T.A.2
Guo, R.-F.3
Speyer, C.L.4
Sarma, J.V.5
Tomlins, S.6
Man, Y.7
Riedemann, N.C.8
Hoesel, L.M.9
Younkin, E.10
Zetoune, F.S.11
Ward, P.A.12
-
31
-
-
34248340981
-
A dual role for complement in allergic asthma
-
DOI 10.1016/j.coph.2007.01.005, PII S1471489207000707, Respiratory/Musculoskeletal
-
Kohl J, Wills-Karp M. A dual role for complement in allergic asthma. Curr Opin Pharmacol. 2007;7:283-289. (Pubitemid 46731203)
-
(2007)
Current Opinion in Pharmacology
, vol.7
, Issue.3
, pp. 283-289
-
-
Kohl, J.1
Wills-Karp, M.2
-
32
-
-
0037215607
-
Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis
-
DOI 10.1124/jpet.102.040329
-
Myers KJ, Murthy S, Flanigan A, et al. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. J Pharmacol Exp Ther. 2003;304:411-424. (Pubitemid 36008955)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.304
, Issue.1
, pp. 411-424
-
-
Myers, K.J.1
Murthy, S.2
Flanigan, A.3
Witchell, D.R.4
Butler, M.5
Murray, S.6
Siwkowski, A.7
Goodfellow, D.8
Madsen, K.9
Baker, B.10
-
33
-
-
0038730729
-
Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice
-
DOI 10.1046/j.1440-1746.2003.03034.x
-
Naito Y, Takagi T, Handa O, et al. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol. 2003;18:560-569. (Pubitemid 36645291)
-
(2003)
Journal of Gastroenterology and Hepatology
, vol.18
, Issue.5
, pp. 560-569
-
-
Naito, Y.1
Takagi, T.2
Handa, O.3
Ishikawa, T.4
Nakagawa, S.5
Yamaguchi, T.6
Yoshida, N.7
Minami, M.8
Kita, M.9
Imanishi, J.10
Yoshikawa, T.11
|